PSNL News and Press, Personalis Inc. From 02/22/21

Second paragraph, first sentence of release dated February 11, 2021, should read: Interested parties may access the live call via telephone by dialing (866) 220-8061 for domestic callers or (470) 495-9168 for international callers, using conference ID: 5065084. (instead of Interested pa...

Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for cancer, and Natera, Inc. (Nasdaq: NTRA), a global leader in cell-free DNA testing, today announced that the two companies have entered into a partnership in the field of personalized oncology. The partnership will pair P...

Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for cancer, announced today it will release its fourth quarter 2020 financial results after the market closes on Thursday, February 25, 2021. In conjunction with the release, the Company will host a conference call and webca...

Personalis (PSNL) appoints of Susan Moriconi as VP of People and Chief Human Resources Officer.Earlier in her career, Ms. Moriconi served as VP of HR at several established healthcare and technology companies – including Boston Scientific, Stanford Healthcare, ...

Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for population sequencing and cancer, today announced the appointment of Susan Moriconi as VP of People and Chief Human Resources Officer. Ms. Moriconi joins Personalis from Omnicell, Inc. (Nasdaq: OMCL), where she most ...

Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for cancer, announced today that its management team will present at the BTIG Virtual MedTech, Digital Health, Life Science and Diagnostic Tools Conference on Thursday, February 18, 2021 at 12:00 p.m. Eastern Time. Abo...

Exact Sciences (EXAS), Natera (NTRA), Personalis (PSNL), and Veracyte (VCYT) are all trading sharply higher today, as Truist Securities initiates coverage with buy recommendations on the stocks.With a price target of $65 and ~21.4% of upside to the previous close, the only laggard in the list...

Shares of Personalis (NASDAQ: PSNL) are down by 12.1% as of 3:48 p.m. EST on Wednesday, after dropping by as much as 15.1%. Investors are selling off the company's stock following its announcement of the pricing of a public offering of common stock. Personalis has been on fire on th...

Personalis (PSNL) has priced its public offering of 3.95M common shares at $38.00/share, for expected gross proceeds of $150.1M. Underwriters' over-allotment is an additional 592.5K shares.Previously (Jan. 26): Personalis trades in red after launching $150M in underwritten public offering F...

Personalis (PSNL) slumped 3.6% in after hours trade after commencing an underwritten public offering of $150M; underwriters granted 30-day option to purchase up to an additional $22.5 M of common stock.Offer size, terms have not yet been disclosed. For further details see: Per...